1. “The Physician Payment Sunshine Act: An Important First Step in Mitigating Financial Conflicts of Interest in Medical and Clinical Practice,”;Stamatoglou;John Marshall Law Review,2012
2. Physician-Owned Specialty Hospitals and the Patient Protection and Affordable Care Act: Health Care Reform at the Intersection of Law and Ethics
3. 28. Id., at 326. We do have the benefit of a few previously published findings. For example, most patients interviewed in a cancer-research trial neither worried about nor seemed to care greatly about financial ties between researchers or institutions and life science companies. Hampson, L. A. et al, “Patients' Views on Financial Conflicts of Interest in Cancer Research Trials,” New England Journal of Medicine 355, no. 22(2006): 2330–2337, at 2335.See generally Pearson, S. D. , “A Trial of Disclosing Physicians' Financial Incentives to Patients,” Archives of Internal Medicine 166, no. 6(2006): 623–680 (“Patients who received a disclosure felt more competent to judge the impact of their physician's compensation on their health care, and…. patients who remembered receiving a disclosure reported that it had increased their trust in their primary care physician”). Gibbons, R. V. et al., “A Comparison of Physicians' and Patients' Attitudes toward Pharmaceutical Industry Gifts,” Journal of General Internal Medicine 13, no. 3(1998): 151–154 (finding that patients generally consider pharmaceutical gifts more influential and less appropriate than do their physicians). Mainous, A. G. Hueston, W. J. Rich, E. C. , “Patient Perceptions of Physician Acceptance of Gifts from the Pharmaceutical Industry,” Archives of Family Medicine 4, no. 4(1995): 335–339 (finding that patients are more likely to see personal gifts to physicians as having negative effects on both the cost and quality of health care than gifts – such as drug samples – that might have patient benefit).
4. 44. Centers for Medicare and Medicaid Services, “Open Payments User Guide for Industry” (July 2013), at 1.1b.
5. The Unintended Consequences of Conflict of Interest Disclosure